Franklin Resources (BEN)
NYSEFinancialsAsset ManagementSnapshot 2026-07-07
Reading BEN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BEN free→NYSEFinancialsAsset ManagementSnapshot 2026-07-07
Reading BEN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BEN free→QuarterlyIQ Insights · BEN
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $34.37. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $34 BEN trades at 13× p/e, below its 19× p/e peer median, but our blended $30 fair value sits below the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $26–$34. Even valued only for durable growth at sustainable margins, it's worth about $38 — above today's price, so the premium reflects that growth case, not pure multiple expansion. Not investment advice.
$26.00 – $34.00 (median $31.00) · 8 analysts · as of 2026-06-26
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $31.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $13.97 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $5.56 | — | — | TTM | high |
| graham number | 12M | $38.29 | — | — | TTM | high |
| Mgmt guidance | 12M | $16.88 | 18.6 | 0.91 | Mgmt | high |
| Peer P/B | 12M | $42.28 | 1.7 | 25.35 | TTM | high |
| Peer P/FCF | 12M | $24.35 | 13.8 | 1.76 | TTM | high |
| Peer P/E | 12M | $47.67 | 18.6 | 2.57 | TTM | high |
| Peer P/S | 12M | $51.62 | 3.0 | 17.43 | TTM | high |
| PEG | 12M | $44.35 | 17.3 | 2.57 | TTM | high |
| residual income | 12M | $26.01 | — | — | TTM | high |
| Own P/E history | 12M | $26.22 | 10.2 | 2.57 | TTM | high |
| triangulated | 12M | $49.21 | 18.6 | 2.65 | Triangulated | high |
| Mgmt guidance | 3Y | $25.43 | 18.6 | 1.37 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $44.64 | 1.7 | 26.76 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $17.00 | 13.8 | 1.23 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $66.77 | 18.6 | 3.60 | Analyst | medium |
| Peer P/S | 3Y | $57.67 | 3.0 | 19.47 | Analyst | medium |
| PEG | 3Y | $62.11 | 17.3 | 3.60 | Analyst | medium |
| Own P/E history | 3Y | $36.72 | 10.2 | 3.60 | Analyst | medium |
| Mgmt guidance | 5Y | $33.42 | 18.6 | 1.80 | Mgmt(prov.) | high |
| Peer P/B | 5Y | $46.28 | 1.7 | 27.75 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $13.37 | 13.8 | 0.97 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $71.78 | 18.6 | 3.87 | Analyst | high |
| Peer P/S | 5Y | $62.00 | 3.0 | 20.93 | Analyst | high |
| PEG | 5Y | $66.77 | 17.3 | 3.87 | Analyst | high |
| Own P/E history | 5Y | $39.48 | 10.2 | 3.87 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.